X-chromosome inactivation patterns are unbalanced and affect the phenotypic outcome in a mouse model of rett syndrome - PubMed (original) (raw)

X-chromosome inactivation patterns are unbalanced and affect the phenotypic outcome in a mouse model of rett syndrome

Juan I Young et al. Am J Hum Genet. 2004 Mar.

Abstract

Rett syndrome (RTT), a neurodevelopmental disorder affecting mostly females, is caused by mutations in the X-linked gene encoding methyl-CpG-binding protein 2 (MeCP2). Although the majority of girls with classic RTT have a random pattern of X-chromosome inactivation (XCI), nonbalanced patterns have been observed in patients carrying mutant MECP2 and, in some cases, account for variability of phenotypic manifestations. We have generated an RTT mouse model that recapitulates all major aspects of the human disease, but we found that females exhibit a high degree of phenotypic variability beyond what is observed in human patients with similar mutations. To evaluate whether XCI influences the phenotypic outcome of Mecp2 mutation in the mouse, we studied the pattern of XCI at the single-cell level in brains of heterozygous females. We found that XCI patterns were unbalanced, favoring expression of the wild-type allele, in most mutant females. It is notable that none of the animals had nonrandom XCI favoring the mutant allele. To explore why the XCI patterns favored expression of the wild-type allele, we studied primary neuronal cultures from Mecp2-mutant mice and found selective survival of neurons in which the wild-type X chromosome was active. Quantitative analysis indicated that fewer phenotypes are observed when a large percentage of neurons have the mutant X chromosome inactivated. The study of neuronal XCI patterns in a large number of female mice carrying a mutant Mecp2 allele highlights the importance of MeCP2 for neuronal viability. These findings also raise the possibility that there are human females who carry mutant MECP2 alleles but are not recognized because their phenotypes are subdued owing to favorable XCI patterns.

PubMed Disclaimer

Figures

Figure 1

Figure 1

Penetrance of phenotypes caused by the _Mecp2_308 allele. Each of the four panels shows an image of a mutant female mouse and of a wild-type female litter mate (inset). The percentage of animals of each sex manifesting a particular phenotype is shown below each panel. A, Representative image of a female with DF. The inset shows a wild-type litter mate with shiny and groomed fur. B, A picture taken at a shutter speed of 1 s reveals the tremor as a shadow effect over the mouse’s silhouette (arrows). The sharp inset picture of a wild-type mouse was taken at the same shutter speed. C, PLs that sometimes extend to the ears. Note also the disarranged appearance of the fur. Inset shows a normal eye in a wild-type litter mate. D, SFMs, inferred by looking at this picture taken with a shutter speed of 1 s. The arrow points to the forepaws of the mutant female, which have a shadow because of the rapid movements (see video by Shahbazian et al. [2002_a_] at the Neuron Web site).

Figure 2

Figure 2

Determination of XCI patterns in the cerebellum of Mecp2 308/X females by confocal laser scanning microscopy. Costaining with anti-calbindin antibody (red) and an antibody against the C-terminus of MeCP2 (green) (see lower diagram for antigen localization) allows us to label all PCs (calbindin) and identify neurons that express the wild-type Mecp2 allele (cells positive for calbindin and Mecp2 have yellow nuclei). Note that the majority of PCs are immunoreactive for the MeCP2 antibody. Arrows mark the few cells expressing mutant Mecp2 (nonimmunoreactive for α-MeCP2). Each panel is a representative example of immunofluorescence, visualized at increasingly higher magnifications. Scale bar = 20 μm.

Figure 3

Figure 3

Distribution of XCI patterns in Mecp2 308/X female mice. Values on the _X_-axis represent the percentage of cells that have the wild-type X chromosome active, as assayed by coimmunofluorescence. Among a total of 45 female mice, none had <54% of cells with the wild-type chromosome as the active one.

Figure 4

Figure 4

XCI patterns in midbrain and cerebral cortex of Mecp2 308/X female mice. A and B, Double immunofluorescence for the detection of wild-type MeCP2 (green) and TH (red) was used to determine the XCI pattern in catecholaminergic neurons in the midbrain. Arrows denote cells that have the X chromosome bearing the mutant Mecp2 as the active one. C, Visualization of coimmunolabeling of Mecp2 (green) and parvalbumin (red) in the cerebral cortex by confocal microscopy. D, Same as in panel C, but a single focal section is shown, to demonstrate the definitive identification of cells expressing the wild-type (arrowhead) versus the mutant (arrow) Mecp2 allele. Scale bar = 20 μm.

Figure 5

Figure 5

Selective growth advantage of neurons expressing the wild-type allele when grown in culture. The proportion of neurons expressing either wild-type or truncated Mecp2 allele was determined by indirect immunofluorescence in hippocampal neurons from an E18 female _Mecp2_308/X embryo cultured for 4 or 7 d (A) and in neurons from mixed cultures derived from _Mecp2_308/Y and Mecp2+/Y embryos (1:1 ratio) cultured for 7 d (B). White bars = neurons expressing wild-type MeCP2. Gray bars = neurons expressing truncated MeCP2.

Figure 6

Figure 6

Correlation between degree of XCI skewing and phenotype. We divided the population of 45 females into three groups, according to their XCI patterns, and plotted them against the percentage of mice expressing a particular phenotype for each range of XCI patterns (A). Logistic regression analysis indicated that a unit increase in XCI was associated with a 16%, a 21%, a 9%, and a 12% decrease in the odds of Tr (

P<.01

), SFM (

P<.01

), DF (

P<.06

), and PL (

P<.02

), respectively. B, The cumulative number of phenotypes presented by the animals in each group plotted against the XCI groups. A significant difference was detected among XCI pattern groups (

P<.001

), and further testing indicated differences between groups 1 (54%–70%) and 2 (71%–77%) (

P<.05

), between groups 1 and 3 (>78%) (

P<.001

), and between groups 2 and 3 (

P<.02

).

Similar articles

Cited by

References

Electronic-Database Information

    1. Neuron, http://www.neuron.org/content/full/35/2/243/DC1 (for Shahbazian et al. video)
    1. Online Mendelian Inheritance in Man (OMIM), http://www.ncbi.nlm.nih.gov/Omim/ (for RTT) - PubMed
    1. RettBASE: IRSA MECP2 Variation Database, http://mecp2.chw.edu.au/ - PubMed

References

    1. Adler DA, Quaderi NA, Brown SD, Chapman VM, Moore J, Tate P, Disteche CM (1995) The X-linked methylated DNA binding protein, Mecp2, is subject to X inactivation in the mouse. Mamm Genome 6:491–492 - PubMed
    1. Amir RE, Van den Veyver IB, Schultz R, Malicki DM, Tran CQ, Dahle EJ, Philippi A, Timar L, Percy AK, Motil KJ, Lichtarge O, Smith EO, Glaze DG, Zoghbi HY (2000) Influence of mutation type and X chromosome inactivation on Rett syndrome phenotypes. Ann Neurol 47:670–67910.1002/1531-8249(200005)47:5<670::AID-ANA20>3.3.CO;2-6 - DOI - PubMed
    1. Amir RE, Van den Veyver IB, Wan M, Tran CQ, Francke U, Zoghbi HY (1999) Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl- CpG-binding protein 2. Nat Genet 23:185–18810.1038/13810 - DOI - PubMed
    1. Armstrong DD, Deguchi K, Antallfy B (2003) Survey of MeCP2 in the Rett syndrome and the non-Rett syndrome brain. J Child Neurol 18:653–660 - PubMed
    1. Balmer D, Arredondo J, Samaco RC, LaSalle JM (2002) MECP2 mutations in Rett syndrome adversely affect lymphocyte growth, but do not affect imprinted gene expression in blood or brain. Hum Genet 110:545–55210.1007/s00439-002-0724-4 - DOI - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources